Healthcare Business Review

Advertise

with us

  • Europe
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Sections
    Business Process Outsourcing
    Compliance & Risk Management
    Consulting Service
    Facility Management Services
    Financial Services
    Healthcare Construction
    Healthcare Digital Marketing
    Healthcare Education
    Healthcare Marketing
    Healthcare Procurement
    Healthcare Staffing
    Medical Transcription and Translation
    Medical Transportation
    Psychological Services
    Radiology
    Therapy Services
    Waste Management
    Business Process Outsourcing
    Compliance & Risk Management
    Consulting Service
    Facility Management Services
    Financial Services
    Healthcare Construction
    Healthcare Digital Marketing
    Healthcare Education
    Healthcare Marketing
    Healthcare Procurement
    Healthcare Staffing
    Medical Transcription and Translation
    Medical Transportation
    Psychological Services
    Radiology
    Therapy Services
    Waste Management
  • Contributors
  • News
  • Vendors
  • Conferences
  • CXO Awards
×
#

Healthcare Business Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Business Review

Subscribe

loading

Thank you for Subscribing to Healthcare Business Review Weekly Brief

  • Home
  • Contributors

Neuro feedback Training for Opiate Addiction

Healthcare Business Review

Lawrance Weinstein, Chief Medical Officer, American Addiction Centers
Tweet

The disease of addiction, like other psychological conditions such as ADHD and obsessive-compulsive disorder, is a neurological based ailment. The abnormalities in the brain that result in addiction are extensive, complex and varied, regardless of the substance used by an individual. Equally, the abnormalities in the brain caused by addiction are just as intricate and diverse. Using the example of opioid use disorder, the brain alterations due to a substance can be explained.


The chemicals in opiates travel through an individual’s bloodstream and attach to opioid receptors throughout the body, including the brain. The resultant effect is pleasure. Opiates utilized for pain can be very effective, but when used in the absence of pain, various circuits in the brain are reconditioned and can motivate repeated use.


Medication-assisted treatment is considered the gold standard for the treatment of substance use disorders. The efficacy of medications such as methadone, buprenorphine and naltrexone has been proven and the use of medication-assisted treatment has been clinically proven to reduce the death rate by 50 percent or more when used in conjunction with psychological treatment and support.


The development of opioid agonists and other medications that curb usage in various substances came about through extensive research, and as more and more scientific advances are made, we have the opportunity to expand upon and develop new treatment methods.


The prevailing psychiatric condition that results in cognitive and behavioral impairment is substance use disorder. The abuse of alcohol and/or illicit substances causes identifiable changes in brain activity that can be seen in a number of electroencephalographic methods.


The treatment of substance use disorders via neurofeedback was initially made popular by Eugine Peniston. In his approach, the frequency of alpha and theta brain waves were altered, and with repeated sessions, long-term abstinence from alcohol and a change in personality testing was seen.


Because the Peniston Protocol did not have as much success with other substance use disorders, years later, William Scott and David Kaiser, Ph.D., modified the treatment. By treating patients who abused stimulants with electroencephalogram protocols originally designed for attention deficit followed by the Peniston Protocol, substantial improvement was seen in long-term abstinence rates. This method is now widely known as the Scott-Kaiser modification.


Neurofeedback treatment is a safe and non-invasive procedure that has previously produced positive results in the treatment of other psychological ailments such as depression and anxiety. 


This form of therapy, depending on the ailment being addressed, requires the strategic placement of electrodes on the patient’s scalp. This allows the treating physician to view theindividual’s electrical output of neuronal activity in the areas where the electrodes are placed. This is also called an EEG or electroencephalograph. From this EEG, the amplitudes and frequencies of the brain waves can be measured and the proper treatment can commence.


Historically, low-resolution electromagnetic tomography (LORE-TA) has been the most successful type of neurofeedback used to treat addiction. It has also used to treat depression, increase relaxation and allows for healing from trauma. In this treatment, electrodes are placed on the occipital lobes, which is the area of the brain that processes visual memories; on the parietal lobes, which is the area of the brain related to problem solving; and the sensorimotor cortex, located in the parietal lobe, which is the area of the brain associated with the conscious control of movement.


Medication-assisted treatment is considered the gold standard for the treatment of substance use disorders


Alpha/theta protocol is the training used to treat addiction, so after the electrodes are placed, the patient receives auditory feedback from the treating physician to perform different brain functions. Studies have shown that neurofeedback training is effective in treating substance used disorder and reducing the craving of a substance.


The practice of utilizing neurofeedback in the treatment of addiction, in addition to other evidence-based treatment methods, has shown some promise, but more research into this area is required. Thus far, the use of PET scans and SPECT scans, both FDA-approved for psychiatric indications and mental health, have been used to monitor functional activity in the brain and identify patterns that correlate with addiction and behavioral health disorders. Based on the fact that this type of imaging has been deemed appropriate for mental and behavioral health treatment, it only follows that more research into neuro feedback technology and treatment is a necessity.


Over the past few years, we have seen the devastation caused by addiction, namely the opioid epidemic, and the damage left in its wake. Tens of thousands of people die each year from this disease, and it’s imperative that treatments with the ability to alleviate problems caused by addiction be made available to the public as soon as they are available. 


Weekly Brief

loading
> <
  • Current Issue
  • Current Issue

Read Also

Resilience in Modern Healthcare

Resilience in Modern Healthcare

Imana Mo Minard MSN-ed, RN, CENP, EMT-P, Director of Nursing, Corewell Health East
READ MORE
Leading High-Reliability Healthcare Delivery

Leading High-Reliability Healthcare Delivery

Dr Ana Maria Y. Jimenez, Executive Director of Nursing, Aspen Medical – Fiji
READ MORE
Importance of Safety in Testosterone Therapy

Importance of Safety in Testosterone Therapy

Mayo Clinic, Director of Endocrinology Services, Maria Lopez
READ MORE
Building Sustainable Care Models through APP Leadership

Building Sustainable Care Models through APP Leadership

Truett Smith, Director of Advanced Practice, Primary Care, Atrium Health
READ MORE
A Systematic Approach to Radiology Workforce Stabilization: Recruitment, Retention and Technological Optimization

A Systematic Approach to Radiology Workforce Stabilization: Recruitment, Retention and Technological Optimization

Julie Singewald, Interim System Shared Clinical Services Operations Leader, Essentia Health
READ MORE
Bridging IT and Healthcare for Smarter Care

Bridging IT and Healthcare for Smarter Care

Benedict Sulaiman, Director of IT-CTO, Mandaya Hospital Group
READ MORE

A Systematic Approach to Radiology Workforce Stabilization: Recruitment, Retention and Technological Optimization

Julie Singewald, Interim System Shared Clinical Services Operations Leader, Essentia Health

Bridging IT and Healthcare for Smarter Care

Benedict Sulaiman, Director of IT-CTO, Mandaya Hospital Group

Innovating Pediatric Healthcare with Genomics

Dr. Catherine Brownstein, Manager, Molecular Genomics Core Facility, Boston Children's Hospital

Balancing Technology and Humanity in Healthcare Leadership

Richard Phillips, Chief Medical Officer, Baptist Health System KY & IN
Loading...
Copyright © 2025 Healthcare Business Review. All rights reserved. |  Subscribe |  Sitemap |  About us |  Newsletter |  Feedback Policy |  Editorial Policy follow on linkedin
CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://neurotech.healthcarebusinessrevieweurope.com/cxoinsight/neuro-feedback-training-for-opiate-addiction-nwid-914.html